StockData
Vaccinex, Inc. logo

Vaccinex, Inc. (VCNX) stock

VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)

Close on Oct 19, 2026Market cap $3.22MP/E –Yield –

Vaccinex revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Vaccinex's revenue for the twelve months ending Dec 31, 2024 was $601.00K, up 5.4% year over year. For fiscal 2024 it was $601.00K, up 5.4% from the year before. The highest annual figure on record is $900.00K in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2024Dec 31, 2024$601.00K+5.4%
FY2023Dec 31, 2023$570.00K+107.3%
FY2022Dec 31, 2022$275.00K-69.4%
FY2021Dec 31, 2021$900.00K+44.0%
FY2020Dec 31, 2020$625.00K+19.5%
FY2019Dec 31, 2019$523.00K-27.8%
FY2018Dec 31, 2018$724.00K+704.4%
FY2017Dec 31, 2017$90.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024$213.00K–
Q3 FY2024Sep 30, 2024$52.00K+160.0%
Q2 FY2024Jun 30, 2024$232.00K–
Q1 FY2024Mar 31, 2024$104.00K-81.1%
Q4 FY2023Dec 31, 2023$0-100.0%
Q3 FY2023Sep 30, 2023$20.00K-60.0%
Q2 FY2023Jun 30, 2023$0–
Q1 FY2023Mar 31, 2023$550.00K+1000.0%
Q4 FY2022Dec 31, 2022$225.00K–
Q3 FY2022Sep 30, 2022$50.00K-94.1%
Q4 FY2021Dec 31, 2021$0–
Q3 FY2021Sep 30, 2021$50.00K-92.0%
Q2 FY2021Jun 30, 2021$0–
Q1 FY2021Mar 31, 2021$850.00K+110.4%
Q4 FY2020Dec 31, 2020$0-100.0%
Q3 FY2020Sep 30, 2020$625.00K+564.9%
Q4 FY2019Dec 31, 2019$0-100.0%
Q3 FY2019Sep 30, 2019$404.00K+104.0%
Q2 FY2019Jun 30, 2019$25.00K-80.2%
Q1 FY2019Mar 31, 2019$94.00K-54.4%
Q4 FY2018Dec 31, 2018$194.00K–
Q3 FY2018Sep 30, 2018$198.00K–
Q2 FY2018Jun 30, 2018$126.00K–
Q1 FY2018Mar 31, 2018$206.00K–

More Vaccinex figures

See a number that looks wrong?